Betaine: a trial in women with overweight observes effects on two biological markers

What the researchers measured

Participants received either anhydrous betaine at 3 g per day or a placebo for eight weeks. This dose describes the intervention studied, not a recommendation for supplementation. The sample size is not stated in the abstract provided.

The researchers measured the levels of two mitochondria-associated enzymes in peripheral blood mononuclear cells: citrate synthase and cytochrome c oxidase. In plasma, they also assessed the activity of three antioxidant enzymes and the concentration of oxidized glutathione. These are biological markers, not direct measures of a perceived or clinical benefit.

Two signals, but no overall improvement

For citrate synthase, the difference in change between the betaine and placebo groups was 102.3 µg/mg of protein, with a 95% confidence interval ranging from 3.19 to 201.4. This wide interval leaves considerable uncertainty about the magnitude of the effect. The before-and-after changes within each group were not statistically significant.

Plasma catalase activity also changed differently between the groups, with a significant increase only in the betaine group. However, no significant effect was observed for cytochrome c oxidase, superoxide dismutase, glutathione peroxidase or oxidized glutathione.

The result is therefore selective. A change in the level of one enzyme is not enough to establish that mitochondria produce more energy. Similarly, an increase in catalase alone does not demonstrate an overall improvement in antioxidant defenses.

What can be concluded from this trial

The randomized comparison with a placebo supports the existence of an effect on some parameters measured in this population. However, the authors believe that their physiological significance and the underlying mechanisms still need to be studied.

The dossier contains only the PubMed abstract, not the full text. It does not allow verification of the sample size, adverse effects, funding or conflicts of interest. These results are therefore insufficient to justify supplementation to improve energy, metabolic health or longevity, or to generalize them to other populations.

What we can take away

Betaine changed two biological markers in this eight-week trial. The clinical relevance of these changes remains to be determined.